|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| A61K 38/20 | |||
| A61P 35/00 | |||
| C07K 16/24 |
| (11) | Patento numeris | 3443985 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18199427.8 |
| Europos patento paraiškos padavimo data | 2011-08-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 37609710 P | 2010-08-23 | US | |
| 40675910 P | 2010-10-26 | US | |
| 41118310 P | 2010-11-08 | US | |
| 201161480635 P | 2011-04-29 | US |
| (72) |
SIMARD, John, US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | TREATMENT FOR NEOPLASTIC DISEASES |
| TREATMENT FOR NEOPLASTIC DISEASES |